Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

OptraSCAN anuncia CytoSiA, uma solução digital completa para digitalização e análise de lâminas de citologia, a preços acessíveis
  • USA - Deutsch
  • USA - Français
  • USA - English
  • Israel - English
  • Latin America - español
  • Brazil - Português

Optra_Scan_Logo

News provided by

OptraSCAN Inc.

May 26, 2021, 00:51 ET

Share this article

Share toX

Share this article

Share toX

- A ferramenta inteligente CytoSiA da OptraSCAN – Para melhorar o rastreamento em citologia por meio de uma solução inigualável de análise de imagens baseada em qualidade de imagem e inteligência artificial 

SAN JOSE, Califórnia, e PUNE, Índia, 26 de mayo de 2021 /PRNewswire/ -- A OptraSCAN®, fornecedora líder de soluções em patologia digital sob demanda, anunciou hoje sua solução inteligente CytoSiA para digitalização e análise rápida, mas acessível, de lâminas de citologia em meio líquido e Papanicolau. É uma solução completa composta por scanner digital de patologias, armazenamento e algoritmos poderosos de inteligência artificial (IA) da OptraSCAN para ajudar patologistas e citotecnologistas a rastrear e detectar câncer cervical, lesões pré-cancerosas, células atípicas e todas as outras categorias de citologia. Vários hospitais e laboratórios de patologia em todo o mundo já instalaram a CytoSiA  e estão obtendo resultados melhores para os pacientes, aumento da eficiência e produtividade necessária para lidar com a demanda cada vez maior de casos de citologia. 

Continue Reading
OptraScan_CytoSiA
OptraScan_CytoSiA

"A OptraSCAN está redefinindo o rastreamento do câncer cervical com a introdução da CytoSiA, que oferece uma infinidade de recursos para rastrear com eficácia as lâminas de citologia em meio líquido e Papanicolau, a fim de diferenciar células cervicais normais de anormais utilizando as classificações Bethesda em células normais a carcinoma de células escamosas (NILM/LSIL/HSIL/SCC)", disse Abhi Gholap, fundador da OptraSCAN. "Com uma linha de dispositivos de rastreamento que processam de 50 lâminas a cinco mil lâminas por semana a um preço extremamente acessível", acrescentou.

Os scanners digitais da OptraSCAN podem rastrear lâminas de citologia de 15x15 mm com ampliação de 40x em menos de 60 segundos, ao mesmo tempo que geram imagens da mais alta qualidade. A CytoSia incorpora tecnologia patenteada de imagem composta, que encontra todos os pixels em foco de várias imagens no plano Z e remonta para criar uma imagem composta de camada única. Essa tecnologia de imagem composta é consideravelmente eficiente em comparação com a tecnologia tradicional de empilhamento em Z. Ela permite o rastreamento rápido e preciso de toda a lâmina em segundos. Esse nível de precisão e qualidade é imprescindível para analisar as amostras. Além disso, apresenta ao scanner imagens de campos que seriam essenciais para a interpretação citológica, as categoriza e filtra as redundâncias.

A CytoSiA , quando utilizada como ferramenta de diagnóstico complementar, notifica os patologistas quando existem inconsistências entre sua interpretação e os resultados do algoritmo de IA, oferecendo proteção contra erros ou interpretações equivocadas, ao mesmo tempo que melhora a qualidade geral do atendimento.

Características da CytoSiA: 

  • Computação automatizada de adequação de amostras para todas as imagens de citologia de lâminas
  • Identificação de células anormais e outros organismos com base em características morfológicas e classificação baseada em IA utilizando classificação Bethesda
  • Identificação de organismos reativos, endometriais, Actinomyces, Candida, "clue cells", Trichomonas vaginalis e herpes
  • Identificação de organismos como sangue, inflamação e lubrificante

"A análise de imagem baseada em IA exige imagens de qualidade superior", disse a Dra. Aparna Joshi, diretora médica da OptraSCAN. "Nossa equipe desenvolveu uma tecnologia de imagem inteligente que transforma lâminas de vidro físicas de citologia em imagens digitais com uma clareza excepcional. A análise avançada de imagens e a padronização agora são possíveis com essa qualidade de digitalização", ela acrescentou.

Entre em contato com a OptraSCAN 

Sobre a OptraSCAN, Inc:

A OptraSCAN® é pioneira no sistema On-Demand Digital Pathology® e se dedica a oferecer soluções totalmente integradas e acessíveis que maximizarão seu retorno sobre o investimento e melhorarão o desempenho de seus serviços de patologia. Uma empresa com certificação ISO 13485, que oferece scanners de lâminas para uso em DIV com a marca CE, a OptraSCAN está trabalhando para eliminar as barreiras à "transformação digital", independentemente do tamanho do laboratório de patologia, da produtividade do laboratório ou da localização geográfica.

A solução integral de patologia digital da OptraSCAN oferece a obtenção eficaz de imagens de lâminas inteiras, visualização, armazenamento, compartilhamento em tempo real, relatórios e soluções de análise de imagens baseadas em IA e aprendizado de máquina, por meio de modelo de compra sob demanda ou total. Siga-nos no LinkedIn e no Twitter.

Contato para a imprensa: 

Anjana Athanikar
Manager – Comunicações de marketing 
[email protected]

Logotipo: https://mma.prnewswire.com/media/1517923/Optra_Scan_Logo.jpg  
Foto: https://mma.prnewswire.com/media/1517924/OptraScan_CytoSiA.jpg

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.